The Rise of AI+ Healthcare in China

Mr. Chen established Delos Capital in 2015 and is its Managing Partner. Based in Hong Kong, Delos Capital is a life sciences fund that finds, funds and foster innovation across its global network to help advance life sciences in the US and Greater China.

Prior to establishing Delos, Mr. Chen was a Partner and Co-Head of Asia at Permira, a European private equity firm with global reach and a total committed capital of approximately €44bn.

Prior to joining Permira in 2008, Mr. Chen spent nine years in Investment Banking at Goldman Sachs, where he was a Managing Director and co-headed the General Industrials Group, Asia (excluding Japan).

Prior to that, Mr. Chen was a corporate finance lawyer with Davis Polk in New York and Hong Kong. In addition to founding and managing Delos Capital, Mr. Chen also is the CEO of Curamir Therapeutics Inc., a RNA-based oncology biotechnology company, and Tanvex BioPharma Inc., a US-based biopharma company listed in Taiwan.

Mr. Chen holds Bachelor and Masters degrees from Harvard University and a Juris Doctorate from Harvard Law School.